Cronos Confirms That It Has Received Expressions Of Interest, While Curaleaf Refuses To Comment

Cronos Group (TSX: CRON) has confirmed that it has received what amounts to “a number” of unsolicited indications of interest for the potential sale of the company.

The indications of interest are said to come from third parties, with each involving a potential transaction. Cronos however has not provided details on who is seemingly interested in acquiring the company, instead electing to state that it is in the early stages of reviewing each offer, and that there can be no assurance that anything comes of the discussions.

The announcement follows a rumor that was leaked and reported on by Reuters, who suggested that the Canadian cannabis operator was in discussions to be acquired by Curaleaf Holdings (CSE: CURA), a US-based multi-state operator.

Curaleaf for its part at the request of IIROC this morning commented on the media reports, just to say that the company’s policy is “to refrain from commenting on market rumors.”

The confirmation of third party expressions of interest being received by Cronos all but confirms that the “leak” was conducted in an attempt to get a higher figure in a potential sale. That strategy however has appeared to fail spectacularly, with Cronos closing down 3%, after initially jumping over 19%.


Information for this briefing was found via Sedar, Reuters and the sources mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

How to Still Find 10-Bagger Gold and Silver Stocks | Don Durrett

First Majestic Silver: Jerritt Canyon Is BACK!

Canada May Finally Be Backing Its Battery Supply Chain | John Passalacqua – First Phosphate

Recommended

Kirkland Lake Discoveries Drills 39.35 g/t Gold Over 16.4 Metres As Mirado Continues To Grow

Antimony Resources Expands Footprint as Soil Sampling Lights Up Ground South of Bald Hill

Related News

Curaleaf: Haywood Reiterates $22 Price Target, Names Firm A Top Pick For 2022

On December 28th, Curaleaf Holdings (CSE: CURA) announced that they have entered into a definitive agreement...

Friday, December 31, 2021, 04:35:00 PM

Ginkgo Bioworks To Go Public Via SPAC Route With Soaring Eagle Acquisition Corp

It appears that Cronos Group (TSX: CRON) (NASDAQ: CRON) might be losing its star player....

Tuesday, May 11, 2021, 10:30:00 AM

Curaleaf: Canaccord Raises Price Target To $23.50

Wednesday, Canaccord came out with their updated valuations for the large three multi-state operators. In...

Saturday, January 16, 2021, 01:43:00 PM

Curaleaf Holdings Sees Revenues Climb 55% To $182.4 Million, Announces CEO Transition

Curaleaf Holdings (CSE: CURA) this evening reported its third quarter financial results, reporting total revenue...

Tuesday, November 17, 2020, 04:39:50 PM

Lord Jones! Cronos Group Generates Positive Net Income Thanks to Declining Share Price

This morning Cronos Group (TSX: CRON, NASDAQ: CRON) reported their third quarter results. We organized...

Tuesday, November 12, 2019, 10:32:28 AM